Document is current

Any future updates will be listed below

A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1007/s00280-015-2914-5

Published Online: 2015-12-09

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark